Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients

NCT07039877 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphobkastic Leukemia
Acute Lymphoblastic Leukaemia Recurrent
Philadelphia Chromosome Negative ALL

Interventions

DRUG: Venetoclax low dose with itraconazole

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez